Histone deacetylase activity is decreased in peripheral blood monocytes in patients with COPD

Journal of Inflammation (United Kingdom)

Volumn 9, Issue , 2012, Pages

  Chen, Yanwei ^a,b   Huang, Ping ^b   Ai, Wen ^b   Li, Xiaoli ^b   Guo, Wei ^a   Zhang, Jingnong ^b   Yang, Jiong ^a  

^a WUHAN UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Cigarette smoke; Histone deacetylase; Inflammation

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; INTERLEUKIN 8; OXYGEN; PREDNISONE; SALBUTAMOL; SHORT ACTING DRUG; THEOPHYLLINE DERIVATIVE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SMOKING; SPIROMETRY; TREATMENT RESPONSE;

EID: 84862788383     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-9-10     Document Type: Article

References (25)

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J, Am J Respir Crit Care Med 2007 176 532 555 10.1164/rccm.200703-456SO 17507545 (Pubitemid 47403272)
2. From COPD to chronic systemic inflammatory syndrome? Fabbri LM, Rabe KF, Lancet 2007 370 797 799 10.1016/S0140-6736(07)61383-X 17765529 (Pubitemid 47320803)
3. Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD. Aaron SD, Vandemheen KL, Ramsay T, Zhang C, Avnur Z, Nikolcheva T, Quinn A, Respir Res 2010 11 41 10.1186/1465-9921-11-41 20412595
4. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Dentener MA, Creutzberg EC, Schols AM, Mantovani A, van't Veer C, Buurman WA, Wouters EF, Thorax 2001 56 721 726 10.1136/thorax.56.9.721 11514694 (Pubitemid 32831700)
5. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Mannino DM, Ford ES, Redd SC, Am J Med 2003 114 758 762 10.1016/S0002-9343(03)00185-2 12829203 (Pubitemid 36776358)
6. Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Petersen AM, Penkowa M, Iversen M, Frydelund-Larsen L, Andersen JL, Mortensen J, Lange P, Pedersen BK, Lung 2007 185 161 171 10.1007/s00408-007-9000-7 17436040 (Pubitemid 46850166)
7. Differential particulate air pollution induced oxidant stress in human granulocytes, monocytes and alveolar macrophages. Becker S, Soukup JM, Gallagher JE, Toxicol In Vitro 2002 16 209 218 10.1016/S0887-2333(02)00015-2 12020593 (Pubitemid 34521693)
8. Macrophages and the pathogenesis of COPD. Tetley TD, Chest 2002 121 156S 159S 10.1378/chest.121.5-suppl.156S 12010845 (Pubitemid 34497334)
9. Alveolar macrophages as orchestrators of COPD. Barnes PJ, Copd 2004 1 59 70 10.1081/COPD-120028701 16997739
10. Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Pons AR, Noguera A, Blanquer D, Sauleda J, Pons J, Agusti AG, Eur Respir J 2005 25 647 652 10.1183/09031936.05.00062304 15802338 (Pubitemid 40528757)
11. Role of HDAC2 in the pathophysiology of COPD. Barnes PJ, Annu Rev Physiol 2009 71 451 464 10.1146/annurev.physiol.010908.163257 18817512
12. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ, N Engl J Med 2005 352 1967 1976 10.1056/NEJMoa041892 15888697 (Pubitemid 40638367)
13. IL-8 production by macrophages is synergistically enhanced when cigarette smoke is combined with TNF-alpha. Sarir H, Mortaz E, Janse WT, Givi ME, Nijkamp FP, Folkerts G, Biochem Pharmacol 2010 79 698 705 10.1016/j.bcp.2009.10.001 19874800
14. Cigarette smoke attenuates the production of cytokines by human plasmacytoid dendritic cells and enhances the release of IL-8 in response to TLR-9 stimulation. Mortaz E, Lazar Z, Koenderman L, Kraneveld AD, Nijkamp FP, Folkerts G, Respir Res 2009 10 47 10.1186/1465-9921-10-47 19515231
15. Standardisation of spirometry. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Eur Respir J 2005 26 319 338 10.1183/09031936.05.00034805 16055882 (Pubitemid 41079078)
16. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Cosio BG, Mann B, Ito K, Jazrawi E, Barnes PJ, Chung KF, Adcock IM, Am J Respir Crit Care Med 2004 170 141 147 10.1164/rccm.200305-659OC 15087294 (Pubitemid 38925159)
17. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ, Proc Natl Acad Sci USA 2002 99 8921 8926 10.1073/pnas.132556899 12070353 (Pubitemid 34693659)
18. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Chung KF, Adcock IM, Eur Respir J 2008 31 1334 1356 10.1183/09031936.00018908 18515558
19. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. van Eeden SF, Sin DD, Respiration 2008 75 224 238 10.1159/000111820 18042978 (Pubitemid 351363881)
20. New concepts in the pathobiology of chronic obstructive pulmonary disease. Kim V, Rogers TJ, Criner GJ, Proc Am Thorac Soc 2008 5 478 485 10.1513/pats.200802-014ET 18453359 (Pubitemid 351669174)
21. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity-a common inflammatory phenotype? Sevenoaks MJ, Stockley RA, Respir Res 2006 7 70 10.1186/1465-9921-7-70 16669999 (Pubitemid 43905819)
22. Persistent airway inflammation and emphysema progression on CT in ex-smokers observed for 4 years. Miller M, Cho JY, Pham A, Friedman PJ, Ramsdell J, Broide DH, Chest 2011 139 6 1380 7 10.1378/chest.10-0705 20966041
23. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Willemse BW, ten Hacken NH, Rutgers B, Lesman-Leegte IG, Postma DS, Timens W, Eur Respir J 2005 26 835 845 10.1183/09031936.05.00108904 16264044 (Pubitemid 41632040)
24. Relation between duration of smoking cessation and bronchial inflammation in COPD. Lapperre TS, Postma DS, Gosman MM, Snoeck-Stroband JB, ten Hacken NH, Hiemstra PS, Timens W, Sterk PJ, Mauad T, Thorax 2006 61 115 121 10.1136/thx.2005.040519 16055612 (Pubitemid 43235427)
25. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Garcia-Rio F, Miravitlles M, Soriano JB, Munoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J, Respir Res 2010 11 63 20500811